Glimepiride + Pioglitazone
Composition
This Formulation contains Glimepiride and Pioglitazone as a active pharmaceutical ingrediant
Indications
Used for the treatment of type 2 diabetes mellitus
Side effects
Common side effects include hypoglycemia,weight gain, edema, and dizziness.
Precautions
Cautiosly used in the patients having heart disease.
Contraindications
Contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, renal or hepatic impairment.
Dosage and administration
2-30 mg once in a day, As directed by physician
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai